69
|
217
|
5b3rA |
Crystal structure of metallo-beta-lactamase imp-18 from pseudomonas aeruginosa |
61
|
218
|
5hh4A |
Crystal structure of metallo-beta-lactamase imp-1 in complex with a phosphonate-based inhibitor |
98
|
296
|
5h8jA |
Crystal structure of medicago truncatula n-carbamoylputrescine amidohydrolase (mtcpa) in complex with cadaverine |
87
|
259
|
5axoA |
Crystal structure of metallo-beta-lactamase smb-1 bound to hydrolyzed meropenem |
85
|
259
|
5axrA |
Crystal structure of metallo-beta-lactamase smb-1 bound to 2-mercaptoethanesulfonate |
112
|
312
|
4zvzA |
Co-crystal structures of pp5 in complex with 5-methyl-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid |
88
|
259
|
5b15A |
Crystal structure of metallo-beta-lactamase smb-1 bound to hydrolyzed doripenem |
50
|
189
|
4zc6B |
Crystal structure of human ggt1 in complex with serine borate |
48
|
189
|
4zcgB |
Crystal structure of human ggt1 in complex with glutamate (with all atoms of glutamate) |
49
|
186
|
5gtuA |
Structural and mechanistic insights into regulation of the retromer coat by tbc1d5 |
84
|
259
|
5ayaA |
Crystal structure of metallo-beta-lactamase smb-1 bound to l-captopril |
49
|
189
|
4zbkB |
Crystal structure of human ggt1 in complex with ggstop inhibitor |
61
|
195
|
5fgdJ |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
66
|
233
|
5fhsM |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
66
|
242
|
5fggD |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
65
|
240
|
5fghC |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
63
|
213
|
5fgiN |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
68
|
250
|
5fg7A |
Yeast 20s proteasome beta2-t1a mutant |
70
|
243
|
5fghF |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
57
|
204
|
5fhsI |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
78
|
254
|
5f1mA |
Crystal structure of serine/threonine phosphatase stp1 from staphylococcus aureus |
61
|
222
|
5fgeL |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
68
|
240
|
5fhsC |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
61
|
195
|
5fg9J |
Yeast 20s proteasome beta2-t(-2)v mutant |
68
|
243
|
5fgaF |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
67
|
240
|
5fgiC |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
68
|
233
|
5fgaM |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
67
|
212
|
5fghK |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
56
|
204
|
5fghI |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
62
|
241
|
5fhsG |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
39
|
194
|
5fmgL |
Structure and function based design of plasmodium-selective proteasome inhibitors |
63
|
241
|
5fgeG |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
58
|
222
|
5fgfH |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
65
|
242
|
5fgeD |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
60
|
196
|
5fg7N |
Yeast 20s proteasome beta2-t1a mutant |
68
|
232
|
5fgiM |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
61
|
222
|
5fg7L |
Yeast 20s proteasome beta2-t1a mutant |
69
|
240
|
5fggC |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
67
|
242
|
5fg9D |
Yeast 20s proteasome beta2-t(-2)v mutant |
60
|
222
|
5fggL |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
60
|
196
|
5fgdN |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
60
|
196
|
5fgeN |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
39
|
205
|
5fmgM |
Structure and function based design of plasmodium-selective proteasome inhibitors |
69
|
240
|
5fgeC |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
59
|
222
|
5fghL |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
62
|
195
|
5fggJ |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
34
|
247
|
5fmgH |
Structure and function based design of plasmodium-selective proteasome inhibitors |
71
|
233
|
5fg7M |
Yeast 20s proteasome beta2-t1a mutant |
62
|
222
|
5fgaL |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
59
|
222
|
5fgiL |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |